Neoplants is a Biotechnology Company.
Neoplants has raised $20.0M in total funding. The most recent round was Seed. The last funding was announced in October 2022.
Neoplants's investors include Entrepreneurs First, True Ventures, Heartcore Capital, Partech, Collaborative Fund.
Neoplants is headquartered in Paris, France.
Neoplants is a Biotechnology Company.
Neoplants is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neoplants — Funding & Investors." VCBacked, October 27, 2022, https://www.vcbacked.co/company/neoplants. Accessed October 21, 2026.
VCBacked. (2022). Neoplants — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/neoplants
{{cite web |title=Neoplants — Funding & Investors |url=https://www.vcbacked.co/company/neoplants |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated